Side-by-side comparison of AI visibility scores, market position, and capabilities
Rebranded to Veradigm Jan 2023; $620-635M revenue expected 2024; 180K+ physician users; 3.6% ambulatory EHR market share; sold hospital business to Harris Computer $700M 2022; Nasdaq suspended Feb 2024
Allscripts is a healthcare IT company founded in 1986 in Chicago, historically one of the largest providers of electronic health record and practice management software for physician practices and hospitals in the United States. The company rebranded to Veradigm in January 2023, signaling a strategic pivot from legacy EHR software toward data analytics, life sciences research enablement, and healthcare network intelligence — areas where its 180,000+ physician user base and de-identified patient data assets create differentiated value for pharmaceutical and payer customers.\n\nThe Veradigm platform combines its ambulatory EHR and practice management software with a data and analytics layer that aggregates real-world clinical data for life sciences research, post-market drug surveillance, and population health analytics. Its network of physician practices represents one of the largest ambulatory data footprints in the US, making Veradigm a valuable partner for pharmaceutical companies seeking real-world evidence and patient registries. The company maintains a 3.6% share of the ambulatory EHR market while building out higher-margin analytics and data licensing revenue streams.\n\nVeradigm (formerly Allscripts) targets $620–635M in revenue for 2024, serving 180,000+ physician users across its installed EHR base. The rebrand to Veradigm reflects management's intent to migrate the business model from competitive, commoditizing EHR software toward network and data platform economics. As life sciences companies increase investment in real-world evidence and physicians demand more integrated practice intelligence tools, Veradigm's combination of clinical workflow reach and data network assets gives it a credible platform for this strategic repositioning.
Santa Clara cybersecurity platform (NASDAQ: PANW) $8.0B FY2024 revenue (+16%); platformization 3,600+ customers, Cortex XSIAM AI SOC, $4.2B NGSSAR +42%, competing with CrowdStrike and Microsoft Defender.
Palo Alto Networks, Inc. is a Santa Clara, California-based cybersecurity platform company — publicly traded on the NASDAQ (NASDAQ: PANW) as an S&P 500 Information Technology component — providing network security, cloud security, and AI-driven security operations through three integrated security platforms: Strata (network security — next-generation firewalls, SD-WAN, Zero Trust Network Access), Prisma Cloud (cloud security posture management, cloud workload protection, CSPM/CWPP), and Cortex (AI-driven security operations — XSIAM extended security intelligence and automation management, XDR endpoint detection and response, XSOAR security orchestration) through approximately 15,000 employees worldwide. In fiscal year 2024 (ending July 2024), Palo Alto Networks reported revenues of $8.0 billion (+16% year-over-year), with next-generation security Annual Recurring Revenue (ARR — Prisma Cloud and Cortex subscriptions) growing 42% to $4.2 billion as large enterprise and government customers consolidated security toolsets onto Palo Alto Networks' platform versus maintaining dozens of point solution security vendors. CEO Nikesh Arora (joined 2018 from SoftBank as Chairman and CEO) has executed the "platformization" strategy — convincing large enterprise security buyers to replace 10-15 individual security vendors (email security, endpoint protection, cloud workload protection, network detection) with a consolidated Palo Alto Networks platform contract that provides 80% of point-solution capabilities at 50% of the total cost — using the first-year transition economics to accelerate platform adoption through deferred commitment offers (paying a lower platform price in year 1 in exchange for multi-year platform commitment in years 2-4).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.